Bipolar Disorder and ADHD:

by | Oct 19, 2024 | 0 comments

Bipolar disorder and ADHD often occur together. A 2021 meta-analysis of 71 studies found ADHD in about one in six adults with bipolar disorder, and bipolar disorder in about one in thirteen adults with ADHD.1 Both bring restlessness, distraction and impulsive choices. The difference is time: ADHD is a steady trait that starts in childhood, while bipolar disorder arrives in episodes.

My argument is that the overlap between these two diagnoses is less a hybrid condition than a diagnostic trap, and that the way out is a question about time rather than about symptoms. Has this been true of you nearly every week since grade school, or did it start, build and end? ADHD answers the first way. A manic, hypomanic or depressive episode answers the second. Getting that answer right decides the order of treatment. In a Swedish registry study of 2,307 adults with bipolar disorder, starting methylphenidate without a mood stabilizer was followed by a sharp rise in mania, and starting it alongside one was not.2 Missing either condition costs something. Undetected bipolar disorder can turn an ordinary ADHD prescription into a hospital stay, and undetected ADHD leaves someone whose mood is finally stable still unable to finish what they start.

Tangled web of thin blue lines crossing over a dark, star-flecked background

How often bipolar disorder and ADHD occur together

The best current estimate comes from Carmen Schiweck, Andreas Reif and colleagues, who pooled 71 studies with 646,766 participants from 18 countries. About 17% of adults with bipolar disorder also had ADHD, and about 8% of adults with ADHD also had bipolar disorder.1 The often-repeated line that “up to 20%” of people with bipolar disorder have ADHD is roughly right for that direction, and the Swedish methylphenidate paper used the same phrase.2 The “and vice versa” that usually follows it is not right: the pooled rate in the other direction is less than half as high. Estimates vary widely, partly with the diagnostic system, sample size and country.1 Clinic samples tend to run higher. One clinical review put bipolar disorder at roughly 20% of adult ADHD patients and ADHD at 10% to 20% of bipolar patients.3

An early large American estimate came from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD), a National Institute of Mental Health study. Among its first 1,000 adult participants, 9.5% had lifetime ADHD: 14.7% of the men and 5.8% of the women. Those with ADHD had their first mood episode about five years earlier, had shorter stretches of wellness, were depressed more often, and had higher rates of anxiety disorders and of alcohol and drug problems.4 A 2023 meta-analysis of 43 studies by Francesco Bartoli and colleagues confirmed most of that picture. Adults with both conditions were more likely to be male, had an earlier onset and more mood episodes, especially depressive and mixed ones, and had higher odds of a suicide attempt (odds ratio 1.83) and of alcohol or drug use disorders (about 2.3). They were less likely to have psychotic features. The evidence was rated high quality for the earlier onset and substance problems, moderate for suicide attempts, and low or very low for most of the rest.5

The male skew deserves a second look. Girls and women with ADHD are more often inattentive than hyperactive, and their anxiety and depression can draw a clinician’s eye first, so their ADHD is easier to miss. Patricia Quinn and Manisha Madhoo also note that hormonal changes can affect how ADHD shows up and how it responds to treatment.6 Childbirth matters on the bipolar side. In a meta-analysis covering 5,700 deliveries, women with bipolar disorder who were off preventive medication during pregnancy relapsed after delivery 66% of the time, compared with 23% for those who stayed on it.7 That is a reason to plan a pregnancy with a prescriber, not a reason to make medication decisions alone.

What the DSM changed, and what it did not

Many articles, including an earlier version of this one, say that the DSM-IV did not allow bipolar disorder and ADHD to be diagnosed together and that the DSM-5 lifted that ban in 2013. That is not accurate. The DSM-IV’s exclusion criterion for ADHD ruled out symptoms that occurred only during a pervasive developmental disorder or a psychotic disorder, or that were better accounted for by another mental disorder, a mood disorder included.8 The current manual keeps the same “better explained” test.9 What the 2013 revision dropped was autism spectrum disorder as an exclusion, which is why ADHD and autism can now be diagnosed together. The same revision moved the age by which several symptoms must have appeared from 7 to 12, lowered the symptom threshold for older adolescents and adults from six to five, and renamed ADHD’s subtypes “presentations.”10 The two were being diagnosed in the same people long before 2013: STEP-BD reported both diagnoses in the same patients in 2005, and between 1999 and 2003, 32.2% of American office visits by young people with a bipolar diagnosis also carried an ADHD diagnosis.4, 11 The manual does place the two in different chapters. ADHD is a neurodevelopmental disorder; bipolar disorder has its own chapter, “Bipolar and Related Disorders.”9

The 2013 change that matters most here was on the bipolar side. The DSM-IV defined a manic or hypomanic episode by a change in mood: elevated, expansive or irritable. The DSM-5 added a second core requirement, a persistent increase in activity or energy. Anna Grunze and colleagues report that, in their own research, this cuts the prevalence of manic and hypomanic episodes by at least a third.12 In a Danish study in which 117 people with bipolar disorder rated themselves daily on a smartphone for six to nine months, elevated or irritable mood without increased activity was common, while the two together for the four consecutive days that hypomania requires were rare.13 The stricter definition guards against calling ordinary irritability hypomania, but a restless person with ADHD can still have an irritable week that looks, on a checklist, like both halves of the criterion. Duration and change from the person’s own baseline are what separate them.

The history behind the confusion is mostly about children. Between 1994–95 and 2002–03, office visits in which a young person was diagnosed with bipolar disorder rose from 25 to 1,003 per 100,000 population, roughly fortyfold, while adult visits did not quite double.11 Some of the children given the diagnosis had severe, chronic irritability rather than distinct episodes. Ellen Leibenluft’s group at the National Institute of Mental Health called this “severe mood dysregulation,” and the longitudinal studies she reviewed linked non-episodic irritability in youth to later anxiety and unipolar depression, not bipolar disorder.14 The DSM-5 responded with a new diagnosis, disruptive mood dysregulation disorder, placed among the depressive disorders.9 The pediatric bipolar boom is a reminder that a diagnostic category can spread faster than the evidence for it, a theme in our critical history of the DSM and in R.D. Laing’s challenge to how psychiatry draws the line between madness and sanity.

Trait or episode: how clinicians tell them apart

On a symptom list the two conditions share a great deal: high energy, distractibility, disorganization, impulsivity, physical restlessness and fast speech.3 The DSM-5-TR separates them by their shape over time. A manic episode is a distinct period of abnormally elevated, expansive or irritable mood together with increased activity or energy, present most of the day, nearly every day, for at least a week, or for any length of time if hospitalization is needed. A hypomanic episode needs at least four consecutive days. ADHD needs several symptoms before age 12, in two or more settings, and does not require abnormal mood at all.9 Philip Asherson and colleagues put the clinical rule simply: bipolar disorder is episodic, with stretches of normal mood, though not always normal functioning, and when ADHD is also present its symptoms are still visible between episodes.15 A Canadian task force turned that into a practical test. In someone with a mood disorder, ADHD is best diagnosed when the typical symptoms persist through a period of sustained euthymia, meaning stable, ordinary mood.16

Five questions do most of the sorting in an interview:

  • When did it start? ADHD shows up in childhood, often in report cards and teachers’ comments. Bipolar disorder usually begins later, although in people who also have ADHD it starts about four years earlier on average.3, 1
  • Is it a change? ADHD sounds like a pattern the person has always had. Hypomania sounds like a stretch when they were not themselves, and others usually noticed.
  • What happened to sleep? Decreased need for sleep, such as feeling rested after three hours, is a manic symptom.9 ADHD sleep trouble usually looks different: a delayed body clock, with trouble falling asleep at night and getting up in the morning. One review puts the rate of delayed sleep phase at 73% to 78% of children and adults with ADHD.17 The person with ADHD is tired. The person with mania is not.
  • What does the focus look like? Adults with more ADHD symptoms report more “hyperfocus,” long absorbed stretches on schoolwork, a hobby or a screen.18 In mania, increased goal-directed activity is one of a cluster of symptoms, alongside others such as grandiosity, racing thoughts or pressured speech, and the cluster marks a noticeable change from the person’s usual behavior.9
  • How do the moods move? Clinic-based studies report impairing emotional dysregulation in 34% to 70% of adults with ADHD.19 Those reactions are usually set off by something, like a plan falling through, and belong to the person’s ordinary pattern rather than breaking from it.

Questionnaires help structure the conversation but cannot settle it. The World Health Organization’s Adult ADHD Self-Report Scale has a six-question screener,20 and the Mood Disorder Questionnaire, validated in 198 patients at mood clinics, identified 73% of bipolar spectrum cases with 90% specificity at its standard cutoff.21 Both ask about symptoms, not timelines, so either can light up for the wrong reason. Two other look-alikes complicate the picture. Borderline personality disorder shares impulsivity and emotional dysregulation with ADHD, and all three conditions can be mistaken for one another,15 a comparison we take up in our article on borderline personality disorder and bipolar disorder. Trauma adds another layer, since the irritability, poor concentration and broken sleep of PTSD can pass for either one,9 as described in our article on PTSD and ADHD.

Shared roots: families, genes and which comes first

The overlap is not only a matter of confusing checklists. Henrik Larsson and colleagues linked Swedish national registers for 61,187 people with ADHD and their relatives. Parents, children and full siblings of people with ADHD had roughly 1.8 to 2.5 times the odds of bipolar disorder, and the risk in second-degree relatives was much lower, the pattern expected when genes are shared. The authors concluded that the co-occurrence reflects shared genetic factors rather than a completely separate subtype.22 That finding cuts against a popular idea, repeated in the earlier version of this article, that “bipolar-ADHD” is a distinct neurotype. No such diagnosis exists. Genome-wide studies had found a low and non-significant genetic correlation between the two disorders, but a later analysis combining both data sets identified five genetic loci associated with both, each with effects in the same direction.23

Development is the other thread. A meta-analysis of ten prospective studies, together following 1,248 young people with ADHD, found that about 10% were later diagnosed with bipolar disorder. In the six studies with healthy comparison groups, the risk was roughly nine times higher, though few of the studies were designed to answer this question.24 In a Danish birth cohort of more than 2.4 million people, the incidence of bipolar disorder was 2.17 per 10,000 person-years in people with no earlier ADHD or anxiety diagnosis, 23.86 after ADHD alone, 26.05 after an anxiety disorder alone and 66.16 after both, about thirty times the baseline for the combination.25 Even in that highest-risk group, the yearly rate was under 1%. An adult with ADHD and an anxiety disorder is not destined for bipolar disorder, but the combination is a reason to ask about mood episodes and to keep asking over the years. We look at the anxiety half of that picture in our article on anxiety disorders and ADHD.

Medication safety: why the order of treatment matters

This section describes research, not advice. Decisions about starting, combining or stopping any medication belong with a prescriber who knows your full history.

The worry about stimulants in bipolar disorder is reasonable, and the best data say the risk depends on context. In the Swedish study led by Alexander Viktorin, 2,307 adults with bipolar disorder started methylphenidate between 2006 and 2014. Each person served as their own comparison, which helps control for severity, genetics and early environment. Among people taking methylphenidate without a mood stabilizer, the rate of mania in the next three months was about 6.7 times higher than in untreated periods. Among people already on a mood stabilizer, mania was somewhat less common after the stimulant started (hazard ratio 0.6). The authors concluded that bipolar disorder should be carefully ruled out before anyone starts a stimulant on its own.2

The type of stimulant may matter as well. In a case-control study of 16- to 35-year-olds admitted to McLean Hospital, past-month prescription amphetamine use was linked to higher odds of a first episode of psychosis or mania (adjusted odds ratio 2.68), and the risk rose with dose. Methylphenidate was not linked to higher odds. Because the comparison group was made up of other psychiatric inpatients, the authors acknowledged selection bias.26 In Iceland, 0.38% of the 16,125 adults who started ADHD medication between 2010 and 2022 were hospitalized for first-onset psychosis or mania within a year. That absolute risk is small. It was about eight times the general population rate, although a general population comparison cannot separate the medication from the higher baseline risk that ADHD itself carries. Of the people prescribed ADHD medication again after discharge, about a quarter were readmitted for psychosis or mania.27

Once mood is stable, the picture is more reassuring. In a small trial, 40 children and teenagers with bipolar I or II disorder and ADHD first took the mood stabilizer divalproex for eight weeks. Mania improved substantially in most of them, but ADHD improved in only three. In the placebo-controlled crossover that followed, mixed amphetamine salts improved ADHD symptoms with no significant worsening of mania.28 Two systematic reviews published in 2024 in Bipolar Disorders reached similar conclusions. One pooled five studies with 1,653 participants who were euthymic or depressed and found no increase in mania ratings with stimulants compared with placebo, while calling the evidence preliminary and the studies heterogeneous.29 The other, from the International Society for Bipolar Disorders, reviewed 17 studies and found no increased risk of mania when ADHD medications were used alongside mood stabilizers.30

Guidelines turn this into a sequence. The Canadian Network for Mood and Anxiety Treatments task force recommended that people with both bipolar disorder and ADHD, especially bipolar I, have mood-stabilizing treatment in place before ADHD treatment begins, and it listed cognitive behavioral therapy among the second-line options.16 Asherson’s group described the same expert consensus: treat the bipolar episode first, then the ADHD, in stages.15 Anyone seeking an ADHD evaluation should therefore expect questions about past highs, family history of bipolar disorder and earlier reactions to antidepressants or stimulants, and those questions deserve full answers.

What therapy and brain-based treatments can and cannot do

Very little treatment research has focused on adults with both conditions, and reviews describe a shortage of data.15 The evidence therefore comes from each condition separately. For bipolar disorder, David Miklowitz and colleagues analyzed 39 randomized trials with 3,863 participants. Adding a structured psychotherapy to medication was associated with fewer recurrences (odds ratio 0.56). Psychoeducation that included guided practice in managing the illness worked better in family or group formats than individually, and cognitive behavioral therapy helped stabilize depressive symptoms.31 For adult ADHD, a review of nine randomized trials found that CBT reduced symptoms compared with waiting lists and, by a smaller margin, compared with active control treatments.32 Mindfulness-based approaches showed possible benefits for ADHD symptoms in a meta-analysis of about ten studies.33

The earlier version of this article said that neurofeedback and transcranial magnetic stimulation “show promise” for bipolar-ADHD. Neither has been tested in people with both conditions. For ADHD alone, the largest recent meta-analysis of neurofeedback, 38 randomized trials with 2,472 participants, found no significant improvement when symptoms were rated by people who probably did not know who had received the real treatment, and only a small one when the analysis was limited to trials using standard protocols.34 Our page on what blinded trials show for qEEG neurofeedback and neurostimulation in ADHD goes through that evidence in detail. Transcranial magnetic stimulation is used mainly for depression, and in depression trials that tracked it, treatment-emergent mania occurred in 0.84% of people receiving active stimulation and 0.73% receiving sham, not a significant difference, though most of the published cases involved people with bipolar disorder.35

The strengths question deserves the same honesty. Bipolar disorder has a long association with creative work. Kay Redfield Jamison, a psychologist who has written about her own bipolar illness, made the biographical case in Touched with Fire in 1993.36 Swedish registry data support part of it. Across creative professions as a whole, bipolar disorder was the only diagnosis that was overrepresented, ADHD was not, and first-degree relatives of people with bipolar disorder were overrepresented too.37 Sheri Johnson and colleagues pointed out that much of the thinking in this area was inspired by biographical accounts of poets and musicians, and that the reasons for the link have barely been tested directly.38 The other strengths popular articles credit to “bipolar-ADHD,” such as heightened empathy, quick decisions and unusual resilience, have not, as far as we could find, been studied in this group. Hyperfocus is a real, self-reported experience in ADHD,18 but focus that intensifies alongside grandiosity and lost sleep is a warning sign rather than a gift.

What this looks like in therapy

The early sessions are mostly history. A useful tool is a life chart: a timeline of mood, sleep, energy, work, relationships, substances and medications. ADHD tends to appear on it as a steady line that begins in childhood. Bipolar disorder appears as peaks and troughs with recognizable beginnings and ends. Hypomania can feel like being at one’s best, so people do not always report it, and a partner, a parent or an old report card can supply what memory leaves out. Daily ratings of mood, sleep and activity, on paper or in an app, build the kind of record the Danish smartphone study used,13 and a few months of it can show what a single interview cannot.

Therapy then works on both rhythms at once. For bipolar disorder, the core is protecting sleep and daily routine, learning one’s own early warning signs and making a plan with family for what to do when they appear, which is close to the family and group psychoeducation that the Miklowitz analysis linked to fewer recurrences than the same skills taught individually.31 For ADHD, the work is external structure: written plans, reminders, large tasks broken into small ones, and routines that do not depend on willpower. The two can pull against each other. ADHD can drive a search for stimulation, late nights and new projects, the very things that can destabilize mood. Naming that conflict openly, rather than treating it as a character flaw, is part of the work.

There is also the question of identity. Many people arrive with a trail of labels, such as lazy, moody or too much, and some with a diagnosis that never quite fit. A depth-oriented therapist listens to the story a person tells about themselves, including which parts feel like “me” and which feel like something that happens to me. That distinction maps onto the trait-versus-episode question, and it makes room to grieve two things: the highs a person may need to give up, and the years spent being misread. Ambivalence is normal: hypomania can feel like the truest version of oneself, and a first effective ADHD treatment like the first time one’s mind has worked. Both feelings deserve a hearing, and neither should make the decision alone. Parts-based language can help here: the restless part that needs novelty, the part that remembers the high and misses it, and the part that is tired of being blamed for both.

If your attention problems and mood swings have never quite fit one diagnosis, an evaluation that looks at both, and at the timeline, is a reasonable place to start. Our page on therapy for ADHD and AuDHD describes how we work with attention, and our page on depression and mood disorder treatment covers mood. Medication decisions belong with a prescriber, and therapy works best alongside that care. You can contact us to ask whether we are a good fit. If you are in crisis, call or text 988, the Suicide and Crisis Lifeline, or go to the nearest emergency room. Our list of crisis resources in Birmingham has more local options.

References

  1. Schiweck, C., Arteaga-Henriquez, G., Aichholzer, M., Edwin Thanarajah, S., Vargas-Cáceres, S., Matura, S., Grimm, O., Haavik, J., Kittel-Schneider, S., Ramos-Quiroga, J. A., Faraone, S. V., & Reif, A. (2021). Comorbidity of ADHD and adult bipolar disorder: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews, 124, 100–123. https://doi.org/10.1016/j.neubiorev.2021.01.017
  2. Viktorin, A., Rydén, E., Thase, M. E., Chang, Z., Lundholm, C., D’Onofrio, B. M., Almqvist, C., Magnusson, P. K. E., Lichtenstein, P., Larsson, H., & Landén, M. (2017). The risk of treatment-emergent mania with methylphenidate in bipolar disorder. American Journal of Psychiatry, 174(4), 341–348. https://doi.org/10.1176/appi.ajp.2016.16040467
  3. Brus, M. J., Solanto, M. V., & Goldberg, J. F. (2014). Adult ADHD vs. bipolar disorder in the DSM-5 era: A challenging differentiation for clinicians. Journal of Psychiatric Practice, 20(6), 428–437. https://doi.org/10.1097/01.pra.0000456591.20622.9e
  4. Nierenberg, A. A., Miyahara, S., Spencer, T., Wisniewski, S. R., Otto, M. W., Simon, N., Pollack, M. H., Ostacher, M. J., Yan, L., Siegel, R., Sachs, G. S., & STEP-BD Investigators. (2005). Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: Data from the first 1000 STEP-BD participants. Biological Psychiatry, 57(11), 1467–1473. https://doi.org/10.1016/j.biopsych.2005.01.036
  5. Bartoli, F., Callovini, T., Cavaleri, D., Cioni, R. M., Bachi, B., Calabrese, A., Moretti, F., Canestro, A., Morreale, M., Nasti, C., Palpella, D., Piacenti, S., Nacinovich, R., Riboldi, I., Crocamo, C., & Carrà, G. (2023). Clinical correlates of comorbid attention deficit hyperactivity disorder in adults suffering from bipolar disorder: A meta-analysis. Australian & New Zealand Journal of Psychiatry, 57(1), 34–48. https://doi.org/10.1177/00048674221106669
  6. Quinn, P. O., & Madhoo, M. (2014). A review of attention-deficit/hyperactivity disorder in women and girls: Uncovering this hidden diagnosis. The Primary Care Companion for CNS Disorders, 16(3), Article PCC.13r01596. https://doi.org/10.4088/PCC.13r01596
  7. Wesseloo, R., Kamperman, A. M., Munk-Olsen, T., Pop, V. J. M., Kushner, S. A., & Bergink, V. (2016). Risk of postpartum relapse in bipolar disorder and postpartum psychosis: A systematic review and meta-analysis. American Journal of Psychiatry, 173(2), 117–127. https://doi.org/10.1176/appi.ajp.2015.15010124
  8. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). American Psychiatric Association.
  9. American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). https://doi.org/10.1176/appi.books.9780890425787
  10. Epstein, J. N., & Loren, R. E. A. (2013). Changes in the definition of ADHD in DSM-5: Subtle but important. Neuropsychiatry, 3(5), 455–458. https://doi.org/10.2217/npy.13.59
  11. Moreno, C., Laje, G., Blanco, C., Jiang, H., Schmidt, A. B., & Olfson, M. (2007). National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Archives of General Psychiatry, 64(9), 1032–1039. https://doi.org/10.1001/archpsyc.64.9.1032
  12. Grunze, A., Born, C., Fredskild, M. U., & Grunze, H. (2021). How does adding the DSM-5 criterion increased energy/activity for mania change the bipolar landscape? Frontiers in Psychiatry, 12, Article 638440. https://doi.org/10.3389/fpsyt.2021.638440
  13. Faurholt-Jepsen, M., Christensen, E. M., Frost, M., Bardram, J. E., Vinberg, M., & Kessing, L. V. (2020). Hypomania/mania by DSM-5 definition based on daily smartphone-based patient-reported assessments. Journal of Affective Disorders, 264, 272–278. https://doi.org/10.1016/j.jad.2020.01.014
  14. Leibenluft, E. (2011). Severe mood dysregulation, irritability, and the diagnostic boundaries of bipolar disorder in youths. American Journal of Psychiatry, 168(2), 129–142. https://doi.org/10.1176/appi.ajp.2010.10050766
  15. Asherson, P., Young, A. H., Eich-Höchli, D., Moran, P., Porsdal, V., & Deberdt, W. (2014). Differential diagnosis, comorbidity, and treatment of attention-deficit/hyperactivity disorder in relation to bipolar disorder or borderline personality disorder in adults. Current Medical Research and Opinion, 30(8), 1657–1672. https://doi.org/10.1185/03007995.2014.915800
  16. Bond, D. J., Hadjipavlou, G., Lam, R. W., McIntyre, R. S., Beaulieu, S., Schaffer, A., & Weiss, M. (2012). The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit/hyperactivity disorder. Annals of Clinical Psychiatry, 24(1), 23–37. https://doi.org/10.1177/104012371202400104
  17. Bijlenga, D., Vollebregt, M. A., Kooij, J. J. S., & Arns, M. (2019). The role of the circadian system in the etiology and pathophysiology of ADHD: Time to redefine ADHD? ADHD Attention Deficit and Hyperactivity Disorders, 11(1), 5–19. https://doi.org/10.1007/s12402-018-0271-z
  18. Hupfeld, K. E., Abagis, T. R., & Shah, P. (2019). Living “in the zone”: Hyperfocus in adult ADHD. ADHD Attention Deficit and Hyperactivity Disorders, 11(2), 191–208. https://doi.org/10.1007/s12402-018-0272-y
  19. Shaw, P., Stringaris, A., Nigg, J., & Leibenluft, E. (2014). Emotion dysregulation in attention deficit hyperactivity disorder. American Journal of Psychiatry, 171(3), 276–293. https://doi.org/10.1176/appi.ajp.2013.13070966
  20. Kessler, R. C., Adler, L., Ames, M., Demler, O., Faraone, S., Hiripi, E., Howes, M. J., Jin, R., Secnik, K., Spencer, T., Ustun, T. B., & Walters, E. E. (2005). The World Health Organization Adult ADHD Self-Report Scale (ASRS): A short screening scale for use in the general population. Psychological Medicine, 35(2), 245–256. https://doi.org/10.1017/S0033291704002892
  21. Hirschfeld, R. M., Williams, J. B., Spitzer, R. L., Calabrese, J. R., Flynn, L., Keck, P. E., Lewis, L., McElroy, S. L., Post, R. M., Rapport, D. J., Russell, J. M., Sachs, G. S., & Zajecka, J. (2000). Development and validation of a screening instrument for bipolar spectrum disorder: The Mood Disorder Questionnaire. American Journal of Psychiatry, 157(11), 1873–1875. https://doi.org/10.1176/appi.ajp.157.11.1873
  22. Larsson, H., Rydén, E., Boman, M., Långström, N., Lichtenstein, P., & Landén, M. (2013). Risk of bipolar disorder and schizophrenia in relatives of people with attention-deficit hyperactivity disorder. British Journal of Psychiatry, 203(2), 103–106. https://doi.org/10.1192/bjp.bp.112.120808
  23. O’Connell, K. S., Shadrin, A., Bahrami, S., Smeland, O. B., Bettella, F., Frei, O., Krull, F., Askeland, R. B., Walters, G. B., Davíðsdóttir, K., Haraldsdóttir, G. S., Guðmundsson, Ó. Ó., Stefánsson, H., Fan, C. C., Steen, N. E., Reichborn-Kjennerud, T., Dale, A. M., Stefánsson, K., Djurovic, S., & Andreassen, O. A. (2021). Identification of genetic overlap and novel risk loci for attention-deficit/hyperactivity disorder and bipolar disorder. Molecular Psychiatry, 26(8), 4055–4065. https://doi.org/10.1038/s41380-019-0613-z
  24. Brancati, G. E., Perugi, G., Milone, A., Masi, G., & Sesso, G. (2021). Development of bipolar disorder in patients with attention-deficit/hyperactivity disorder: A systematic review and meta-analysis of prospective studies. Journal of Affective Disorders, 293, 186–196. https://doi.org/10.1016/j.jad.2021.06.033
  25. Meier, S. M., Pavlova, B., Dalsgaard, S., Nordentoft, M., Mors, O., Mortensen, P. B., & Uher, R. (2018). Attention-deficit hyperactivity disorder and anxiety disorders as precursors of bipolar disorder onset in adulthood. British Journal of Psychiatry, 213(3), 555–560. https://doi.org/10.1192/bjp.2018.111
  26. Moran, L. V., Skinner, J. P., Shinn, A. K., Nielsen, K., Rao, V., Taylor, S. T., Cohen, T. R., Erkol, C., Merchant, J., Mujica, C. A., Perlis, R. H., & Ongur, D. (2024). Risk of incident psychosis and mania with prescription amphetamines. American Journal of Psychiatry, 181(10), 901–909. https://doi.org/10.1176/appi.ajp.20230329
  27. Gudbrandsdottir, R. K., Sigurdsson, E., Albertsson, Þ. I., Jonsdottir, H., & Ingimarsson, O. (2025). Risk of hospitalisation for first-onset psychosis or mania within a year of ADHD medication initiation in adults with ADHD. BMJ Mental Health, 28(1), Article e301521. https://doi.org/10.1136/bmjment-2024-301521
  28. Scheffer, R. E., Kowatch, R. A., Carmody, T., & Rush, A. J. (2005). Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. American Journal of Psychiatry, 162(1), 58–64. https://doi.org/10.1176/appi.ajp.162.1.58
  29. Chiorean, A., Jones, B. D. M., Murong, M., Gonzalez-Torres, C., Kloiber, S., Ortiz, A., Rosenblat, J. D., Mulsant, B. H., & Husain, M. I. (2024). Prescribed psychostimulants and other pro-cognitive medications in bipolar disorder: A systematic review and meta-analysis of recurrence of manic symptoms. Bipolar Disorders, 26(5), 418–430. https://doi.org/10.1111/bdi.13440
  30. Miskowiak, K. W., Obel, Z. K., Guglielmo, R., Bonnin, C. D. M., Bowie, C. R., Balanzá-Martínez, V., Burdick, K. E., Carvalho, A. F., Dols, A., Douglas, K., Gallagher, P., Kessing, L. V., Lafer, B., Lewandowski, K. E., López-Jaramillo, C., Martinez-Aran, A., McIntyre, R. S., Porter, R. J., Purdon, S. E., . . . Hasler, G. (2024). Efficacy and safety of established and off-label ADHD drug therapies for cognitive impairment or attention-deficit hyperactivity disorder symptoms in bipolar disorder: A systematic review by the ISBD Targeting Cognition Task Force. Bipolar Disorders, 26(3), 216–239. https://doi.org/10.1111/bdi.13414
  31. Miklowitz, D. J., Efthimiou, O., Furukawa, T. A., Scott, J., McLaren, R., Geddes, J. R., & Cipriani, A. (2021). Adjunctive psychotherapy for bipolar disorder: A systematic review and component network meta-analysis. JAMA Psychiatry, 78(2), 141–150. https://doi.org/10.1001/jamapsychiatry.2020.2993
  32. Young, Z., Moghaddam, N., & Tickle, A. (2020). The efficacy of cognitive behavioral therapy for adults with ADHD: A systematic review and meta-analysis of randomized controlled trials. Journal of Attention Disorders, 24(6), 875–888. https://doi.org/10.1177/1087054716664413
  33. Cairncross, M., & Miller, C. J. (2020). The effectiveness of mindfulness-based therapies for ADHD: A meta-analytic review. Journal of Attention Disorders, 24(5), 627–643. https://doi.org/10.1177/1087054715625301
  34. Westwood, S. J., Aggensteiner, P.-M., Kaiser, A., Nagy, P., Donno, F., Merkl, D., Balia, C., Goujon, A., Bousquet, E., Capodiferro, A. M., Derks, L., Purper-Ouakil, D., Carucci, S., Holtmann, M., Brandeis, D., Cortese, S., Sonuga-Barke, E. J. S., & European ADHD Guidelines Group. (2025). Neurofeedback for attention-deficit/hyperactivity disorder: A systematic review and meta-analysis. JAMA Psychiatry, 82(2), 118–129. https://doi.org/10.1001/jamapsychiatry.2024.3702
  35. Xia, G., Gajwani, P., Muzina, D. J., Kemp, D. E., Gao, K., Ganocy, S. J., & Calabrese, J. R. (2008). Treatment-emergent mania in unipolar and bipolar depression: Focus on repetitive transcranial magnetic stimulation. International Journal of Neuropsychopharmacology, 11(1), 119–130. https://doi.org/10.1017/S1461145707007699
  36. Jamison, K. R. (1993). Touched with fire: Manic-depressive illness and the artistic temperament. Free Press.
  37. Kyaga, S., Landén, M., Boman, M., Hultman, C. M., Långström, N., & Lichtenstein, P. (2013). Mental illness, suicide and creativity: 40-year prospective total population study. Journal of Psychiatric Research, 47(1), 83–90. https://doi.org/10.1016/j.jpsychires.2012.09.010
  38. Johnson, S. L., Murray, G., Fredrickson, B., Youngstrom, E. A., Hinshaw, S., Bass, J. M., Deckersbach, T., Schooler, J., & Salloum, I. (2012). Creativity and bipolar disorder: Touched by fire or burning with questions? Clinical Psychology Review, 32(1), 1–12. https://doi.org/10.1016/j.cpr.2011.10.001

Explore the Other Articles by Categories on Our Blog 

The Most Common Images in Dreams and What They Mean

The Most Common Images in Dreams and What They Mean

Dreams are so commonly associated with therapy because dreams are such a purely projective experience. In a way dreams are our own personal mythology. Many times a patient will bring a recurring dream to therapy that has occurred for many years. Recurring dreams are...

Why Go to Family Counseling

Why Go to Family Counseling

Family counseling in Birmingham, AL is for households stuck in the same argument, a child or teenager whose behavior has taken over the house, or parents pulling in opposite directions. At Taproot Therapy Collective in Hoover, just off I-65 at the Riverchase exit,...

The Freud Legacy: Documentary Evidence of Cover-ups

The Freud Legacy: Documentary Evidence of Cover-ups

 Anna Freud's Impact on Freud's Biographical Scholarship The systematic efforts to control and sanitize the historical record surrounding Freud have had profound and lasting consequences for our understanding of psychoanalysis and its founder. The work of Frederick...

The Ethical Advantage: Why Autistic Minds Are Built for Justice

The Ethical Advantage: Why Autistic Minds Are Built for Justice

Here is a pattern I see constantly in clinical practice: an autistic client accurately identifies an injustice at work, in their family, or in society. They name it clearly. They expect others to recognize the obvious problem and act accordingly. Instead, they're...

What Hospital Hacks Mean for Hospital Liability and Patient Rights

What Hospital Hacks Mean for Hospital Liability and Patient Rights

Your Medical Records Disappeared. Now What? Imagine walking into your therapist's office or your doctor's clinic and hearing five words that stop you cold: "We can't find your records." Not misplaced in a filing cabinet somewhere. Not delayed by a slow system. Gone....

The Hidden Dynamics of Executive Leadership

The Hidden Dynamics of Executive Leadership

The Psychic Infrastructure of Power The modern boardroom is not merely a place of financial calculation; it is a ritual space where the unconscious forces of the collective psyche play out in high definition. While MBA programs teach strategy, they rarely address the...

What is Monotropism? New Tools to Understand Autism

What is Monotropism? New Tools to Understand Autism

Monotropism is a theory of autism, set out by Dinah Murray, Mike Lesser and Wenn Lawson in a 2005 paper, holding that autistic attention tends to gather into a few deep channels of interest instead of spreading across many at once. Inside a channel, focus and...

Love in the Uncanny Valley—The Psychology of AI Companionship

Love in the Uncanny Valley—The Psychology of AI Companionship

The New Relational Landscape Something unprecedented is happening in human relationships. Millions of people are now forming emotional bonds with artificial intelligence. Apps like Replika offer AI companions that remember your conversations, adapt to your...

Magnolia Bark: Mental Health and Anxiety Benefits

Magnolia Bark: Mental Health and Anxiety Benefits

Discover how Magnolia officinalis bark extract offers anxiety relief through GABA modulation similar to Xanax and alcohol, but with hepatoprotective benefits instead of liver damage. Comprehensive guide to honokiol, magnolol, safety, dosing, and clinical applications.

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *